Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Regeneron Pharmaceuticals, Inc. will report its third quarter 2026 financial and operating results on October 30, 2026, before US markets open. The company will hold a conference call and webcast at 8:30 AM Eastern Time to discuss the results. Regeneron is a biotechnology firm focused on developing medicines for serious diseases, utilizing propriet…
Prime Medicine announced FDA clearance of its Investigational New Drug application for PM647, an in vivo Prime Editor targeting the genetic root of Alpha-1 Antitrypsin Deficiency (AATD). The clearance enables initiation of a global Phase 1/2 clinical trial expected to deliver initial data in 2027. PM647 aims to provide a one-time curative therapy a…
Akamai Technologies announced a significant multi-year agreement with Anthropic valued at $11.6 billion to power the growing CPU workload demands driven by AI applications using Akamai's distributed cloud infrastructure. The deal includes potential expansion up to $20 billion and involves equity warrants that could represent up to 5% of Akamai’s st…
Hemab Therapeutics appointed Keli Walbert to its Board of Directors, adding significant commercial expertise as the biotech company advances its clinical-stage pipeline targeting serious blood coagulation disorders. Walbert's extensive commercial leadership, including launches of major biopharmaceutical products, is expected to strengthen Hemab's s…
OFA Group has announced a long-term development vision to create Japan's premier oceanfront cultural destination in Choshi City. The integrated ecosystem will blend classical music and arts with education, wellness, hospitality, and residential real estate, focusing on sustainability and community impact along Chiba's Pacific coast. The project inc…
Forward Industries, a Nasdaq-listed Solana-focused digital asset treasury company, completed a $25 million registered direct offering at $8.00 per share to a single institutional investor. The proceeds will be primarily used to acquire additional SOL tokens, aiming to expand its Solana holdings and increase SOL per share, enhancing shareholder valu…
Live Oak Acquisition Corp. VI completed its initial public offering of 23 million units at $10.00 each, raising $230 million. The blank check company, listed on Nasdaq under the ticker LOVIU, plans to use these funds to pursue a business combination in any industry. The units consist of Class A shares and warrants exercisable upon completion of the…
Amlan International, the animal health business of Oil-Dri Corporation of America, continues its sponsorship of the World Dairy Expo Media Room for the fifth year, underscoring its commitment to the dairy industry. During the event, Amlan's president will discuss mycotoxin challenges impacting dairy herd fertility and overall productivity, emphasiz…
Pfizer offers a mix of reliable cash generation, a 6.1% yield and an advancing R&D pipeline tied to autoimmune and vaccine-adjuvant innovation. At $28.44, the stock sits between its 52-week low and high and shows constructive technicals. This trade ideas targets a mid-term upside while protecting capital with a clear stop.
The Federal Reserve released a pair of regulatory proposals intended to bring payment stablecoins into a bank-like regulatory structure. The primary proposal would require Board-supervised issuers to back coins with permissible high-quality liquid assets - chiefly short-term Treasury bills - and meet standardized capital rules while banning the pro…
AC Immune (ACIU) is a clinical-stage neurodegeneration company trading at a $275m market cap. With recent price action near $2.70, modest technical support, and concentrated short interest, the risk/reward looks favorable for a mid-term swing ahead of ongoing ACI-7104 progress and potential pipeline expansion updates. This trade plan lays out an en…
Brookfield Corporation offers a pragmatic path to high shareholder returns: diverse fee-bearing asset management plus a large operating platform that benefits from asset recycling and selective acquisitions. At $36.56, Brookfield trades below key moving averages with an oversold RSI, a recent bolt-on acquisition that supports growth, and a market c…
Honeywell is trading cheap on headline multiples while its higher-margin software and building-automation exposures sit at the front end of multi-year secular growth. The recent post-spin reset and durable cash generation create a favorable risk-reward for a long, with a clear entry, stop and target over a 180 trading day horizon.
Toll Brothers, a leading US luxury home builder, has officially opened a new amenity center at its Oakbend Wellen Park gated community in Venice, FL. The facility offers resort-style features including a pool, fitness center, clubhouse, sports courts, and trails, enhancing the lifestyle offering for current and future residents. This development co…
Toll Brothers, a leading US luxury home builder, announced the upcoming Cloverhill community in Cumming, Georgia, featuring luxury townhomes and single-family homes near key local amenities and highly regarded schools. The project is planned to open for sales in spring 2027, offering thoughtfully designed homes and resort-style amenities to attract…
CRISPR Therapeutics is a clinical-stage gene-editing company whose shares have recently been buoyed by headlines around an AI developer's discovery that appears to accelerate protein and guide-RNA design. The combination of accelerating commercial revenue from Casgevy, improving margins, and a still-substantial valuation gap makes CRSP a tradable l…
McDonald's pulled back sharply after investor-day positioning, leaving the stock trading near its recent low with an oversold RSI and a 3.1% yield. Fundamentals remain intact: $7.4B in free cash flow, $12.42 EPS and a PE near 19.4. This trade idea lays out a swing buy plan with strict risk controls and a multi-horizon playbook.
Celestica (CLS) looks set to translate 2026 momentum into a 2027 growth phase driven by hyperscale AI demand and an expanding HealthTech portfolio. Fundamentals show improving margins, strong analyst revisions, and healthy cash generation — but the stock trades at a premium and execution risks remain. I lay out a long trade with entry, stop and tar…
DuPont (DD) combines a lean balance sheet, $1.05B of free cash flow and exposure to advanced materials end markets that are expanding on secular trends. At $131, the stock offers upside to prior highs if margins normalize and higher-value mix gains traction. We lay out an actionable long-term trade with entry, stop and target and the key catalysts …
Retail brokerage moomoo said it has observed a 50% increase in users buying cryptocurrency, led by bitcoin activity, while a wider set of tokens is gaining traction. Company executives attribute the growth to new users migrating from other platforms, existing equity and options traders adding crypto, and a broader product offering that includes wal…
AST SpaceMobile sits at the intersection of cellular and space infrastructure with patents that enable standard phones to connect directly to satellites. The stock trades on growth expectations, not today’s revenue; with $3.7B of reported liquidity and a pushed commercial launch to 2027, the setup is a clear binary trade. I am long with an entry at…
Western Digital (WDC) is trading well below levels justified by its cash generation, AI-driven demand growth and supply tightness for high-capacity storage. We lay out a long trade with concrete entry, stop and target, plus the catalysts and risks that could move the stock over the next 180 trading days.
Negotiators in the US Senate are approaching an agreement to speed permitting for major infrastructure projects after the White House offered concessions on how renewable energy projects would be treated. Key senators said legislative language will be produced imminently for review, but a final floor vote may not occur before the House returns from…
SRX Global announced the liquidation of its investments in Vistagen Therapeutics and Greenland Mines, reallocating capital towards a new investment in Onconetix, an AI and robotics company acquiring Realbotix LLC. The strategic move aligns with SRX's focus on AI-driven technology-enabled opportunities to enhance shareholder value.
Bitdeer is transitioning from a pure-play Bitcoin miner into a hybrid miner + AI colocation operator. Recent announcements of long-dated GPU leases (including a 16-year Tydal deal and multi-year Malaysian and A202 commitments) create a recurring revenue backbone. At a market cap of roughly $3.3B and AI Cloud ARR around $86M, the stock looks like a …
